Historical record - last NADAC effective date: 1/4/2017
Product Information
ACTOPLUS MET 15 MG-850 MG TAB is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $9.5147 per EA under NDC 64764015860. Its NADAC has been published 171 times since Nov 28, 2013.
FDA first approved this application on Aug 29, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
850; 15 mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764015860
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/4/2017
Active Ingredients
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021842FDA Approved
8/29/2005
TE Code
AB
On Market Since
8/29/2005
Pharmacological Classes
Price Statistics
The NADAC for ACTOPLUS MET 15 MG-850 MG TAB has been published 171 times since Nov 28, 2013, and over the history we have for it it has risen 64.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5147 per EA |
|---|---|
| All-time high | $9.5147 (Mar 1, 2017) |
| All-time low | $5.7778 (Nov 28, 2013) |
| Median price | $8.4053 |
| Average price | $7.8296 |
| Largest weekly change | +9.9% (Jul 13, 2016) |
| Weeks tracked | 171 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+64.7%
Last surveyed Mar 1, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 20% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACTOPLUS MET 15 MG-850 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ACTOPLUS MET 15 MG-850 MG TAB, manufactured by Takeda Pharmaceuticals America, Inc., is $9.5147 per EA (NDC 64764015860), effective Mar 1, 2017.
How has the price of ACTOPLUS MET 15 MG-850 MG TAB changed over time?
Over the history we have for it, the NADAC for ACTOPLUS MET 15 MG-850 MG TAB has risen 64.7%. It has been tracked across 171 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACTOPLUS MET 15 MG-850 MG TAB?
Since Nov 28, 2013, the NADAC for ACTOPLUS MET 15 MG-850 MG TAB has ranged from a low of $5.7778 (Nov 28, 2013) to a high of $9.5147 (Mar 1, 2017), with a median of $8.4053 per EA.
Are there cheaper alternatives to ACTOPLUS MET 15 MG-850 MG TAB?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACTOPLUS MET 15 MG-850 MG TAB, is $7.6480 per EA — about 20% below ACTOPLUS MET 15 MG-850 MG TAB.
Who manufactures ACTOPLUS MET 15 MG-850 MG TAB?
ACTOPLUS MET 15 MG-850 MG TAB (NDC 64764015860) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.